Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes: a case study with mosunetuzumab in relapsed/refractory follicular lymphoma
Abstract Background and objectives The National Institute for Health and Care Excellence (England’s health technology assessment body) recommend the use of the average treatment effect (ATE) as an estimand for economic evaluations. However there is limited literature on methods to estimate the ATE,...
Saved in:
Main Authors: | Danilo Di Maio, S. A. Mitchell, S. Batson, E. Keeney, Howard H. Z. Thom |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12874-025-02456-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Digital technologies and performance incentives: evidence from businesses in the Swiss economy
by: Johannes Lehmann, et al.
Published: (2025-01-01) -
Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas
by: Elise A. Chong, et al.
Published: (2025-02-01) -
Enhancing Classification Models With Sophisticated Counterfactual Images
by: Xiang Li, et al.
Published: (2025-01-01) -
Counterfactual Based Approaches for Feature Attributions of Stress Factors Affecting Rice Yield
by: Nisha P. Shetty, et al.
Published: (2025-01-01) -
Clarification des positions sur la laïcité et objectivation des idéologies, un double enjeu dans l’École et pour l’École
by: Xavier Riondet, et al.
Published: (2017-12-01)